Rafael Holdings, Inc. owns commercial real estate assets and interests in preclinical and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey. Show more
520 BROAD STREET, NEWARK, NJ, UNITED STATES, 07102, Newark, NJ, 07102, USA
Market Cap
103.5M
52 Wk Range
$1.12 - $3.96
Previous Close
$1.99
Open
$2.04
Volume
47,410
Day Range
$1.92 - $2.04
Enterprise Value
73.59M
Cash
30.5M
Avg Qtr Burn
-7.284M
Insider Ownership
38.12%
Institutional Own.
7.33%
Qtr Updated
04/30/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Trappsol® Cyclo™ (hydroxypropyl-beta-cyclodextrin) Details Niemann-Pick Disease Type C1 (NPC1) | Phase 3 Data readout | |
CPI-613 (devimstat) + hydroxychloroquine Details Solid tumor/s, Cancer, Sarcoma | Failed Discontinued | |
CPI-613 (devimistat) Details Solid tumor/s, Pancreatic cancer, Cancer | Failed Discontinued | |
CPI-613 (devimstat) Details Blood cancer, Cancer, Leukemia, Lymphoma | Failed Discontinued | |
CPI-613 (devimstat) Details Blood cancer, Cancer, Acute myeloid leukemia | Failed Discontinued | |
CPI-613 (devimstat) Details Solid tumor/s, Pancreatic cancer, Cancer | Failed Discontinued |
